Assessment of Efficacy and Optimization of Antiplatelet Therapy in Patients with Ischemic Heart Disease

Simple item page
dc.creatorG. P., Mirzayeva
dc.creatorO. O., Jabbarov
dc.creatorZ. F., Umarova
dc.creatorSh. I., Qodirova
dc.creatorL. D., Tursunova
dc.creatorYu. I., Nadirova
dc.creatorA. M., Rahmatov
dc.date2023-03-10
dc.date.accessioned2023-08-21T09:03:09Z
dc.date.available2023-08-21T09:03:09Z
dc.descriptionThe review article presents the problems of inadequate disaggregant response to deaggregant therapy. So far no reliable information about the frequency and causes of these complications. Cardiovascular diseases stably hold the leading position among the causes of death in the world. Today, as we know, 50% of all deaths in developed countries are caused by coronary heart disease (CHD). It requires astronomical sums to maintain social health population both in terms of improving the quality of life and its extension. It is the great social significance of the problem and its economic side is the main engines of progress in coronary surgery.en-US
dc.formatapplication/pdf
dc.identifierhttps://univerpubl.com/index.php/synergy/article/view/644
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/21310
dc.languageeng
dc.publisherWeb of Synergy: International Interdisciplinary Research Journalen-US
dc.relationhttps://univerpubl.com/index.php/synergy/article/view/644/543
dc.sourceWeb of Synergy: International Interdisciplinary Research Journal; Vol. 2 No. 3 (2023): Web of Synergy: International Interdisciplinary Research Journal; 183-186en-US
dc.subjectIschemic heart diseaseen-US
dc.subjectacetylsalicylic aciden-US
dc.subjectantiplatelet therapyen-US
dc.titleAssessment of Efficacy and Optimization of Antiplatelet Therapy in Patients with Ischemic Heart Diseaseen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Web of Synergy: International Interdisciplinary Research Journal